🔗 Share this article

Chancellor Reeves has stated she is preparing "targeted steps to tackle cost of living pressures" in the forthcoming Budget.

During an interview with media outlets, she stated that lowering price rises is a joint task of both the government and the central bank.

The United Kingdom's inflation rate is projected to be the most elevated among the G7 developed nations this calendar year and next.

Possible Energy Cost Interventions

It is understood the administration could intervene to reduce utility costs, for example by slashing the current 5% level of value-added tax applied on energy supplies.

An additional option is to cut some of the government charges currently included in bills.

Budgetary Limitations and Expert Expectations

The administration will receive the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these measures.

The expectation from most experts is that Reeves will have to introduce tax increases or expenditure reductions in order to adhere to her self-imposed fiscal targets.

Earlier on Thursday, estimates showed there was a £22 billion shortfall for the chancellor to fill, which is at the more modest range of expectations.

"It is a collective responsibility between the central bank and the administration to bear down further on some of the sources of price increases," the Chancellor stated to the BBC in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Revenue Pledges and International Concerns

While much of the focus has been on likely tax rises, the chancellor said the most recent information from the fiscal watchdog had not changed her vow to election pledges not to raise rates on earnings tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with growing international and commercial tensions for the fiscal revenue measures, likely to be targeted on those "wealthiest."

International Trade Tensions

Commenting on worries about the United Kingdom's commercial links with the Asian nation she said: "Our security interests always come first."

Last week's announcement by China to tighten trade restrictions on rare earths and other resources that are essential for high-technology production led US President Donald Trump to propose an additional 100% import tax on imports from the Asian country, increasing the risk of an full-scale commercial conflict between the two global powers.

The American finance chief called China's decision "economic coercion" and "a global supply chain power grab."

Asked about considering the US offer to join its dispute with the Asian nation, the Chancellor said she was "very concerned" by China's actions and called on the Beijing authorities "not to put up barriers and limit trade."

She said the action was "harmful for the world economy and generates additional challenges."

"It is my opinion there are sectors where we need to confront Chinese policies, but there are also valuable prospects to trade with China's economy, including banking sector and other sectors of the economy. We've got to get that equilibrium right."

The chancellor also affirmed she was working with other major economies "regarding our own essential resources approach, so that we are more independent."

NHS Drug Costs and Investment

Reeves also acknowledged that the price the National Health Service spends on drugs could increase as a consequence of current talks with the Trump administration and its drugs companies, in exchange for reduced taxes and investment.

Some of the biggest global drug companies have said lately that they are either pausing or canceling investments in the United Kingdom, with some blaming the low prices they are obtaining.

Recently, the government science advisor said the cost the health service spends on medicines would must rise to prevent firms and pharmaceutical investment leaving the United Kingdom.

Reeves stated to media: "It has been observed because of the pricing regime, that medical research, innovative medicines have not been available in the United Kingdom in the extent that they are in other continental states."

"The objective is to make sure that people receiving care from the National Health Service are able to receive the best life-saving drugs in the globe. And so we are examining all of that, and... seeking to obtain increased investment into Britain."